| Schedule of Earnings Per Share |
The
earnings (loss) per share accounting guidance is discussed in Note 1. Diluted loss per share excludes all dilutive potential shares if
their effect is anti-dilutive. The following table sets forth the computation of the Company’s basic and diluted net earnings (loss)
per share available to common stockholders (unaudited) for the three and nine months ended September 30, 2023 and 2022:
Schedule of Earnings Per Share
| |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
| |
|
Three
Months Ended September 30, |
|
|
Nine
Months Ended September 30, |
|
| |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
| Numerator |
|
|
|
|
|
|
|
|
|
|
|
|
| Net
income (loss) from continuing operations |
|
$ |
(547,113 |
) |
|
$ |
(1,339,865 |
) |
|
$ |
1,544,377 |
|
|
$ |
(4,105,838 |
) |
| Deemed
dividends |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(330,876,369 |
) |
| Net
income (loss) available to common stockholders, continuing operations |
|
|
(547,113 |
) |
|
|
(1,339,865 |
) |
|
|
1,544,377 |
|
|
|
(334,982,207 |
) |
| Net
loss from discontinued operations |
|
|
(1,116 |
) |
|
|
(1,696 |
) |
|
|
(9,213 |
) |
|
|
(7,075 |
) |
| Net
income (loss) available to common stockholders |
|
$ |
(548,229 |
) |
|
$ |
(1,341,561 |
) |
|
$ |
1,535,164 |
|
|
$ |
(334,989,282 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average
number of shares of common stock outstanding during the period - basic |
|
|
31,401,420,083 |
|
|
|
10,569,572,256 |
|
|
|
30,369,571,341 |
|
|
|
4,130,876,898 |
|
| Warrants |
|
|
- |
|
|
|
- |
|
|
|
20,977,778,506 |
|
|
|
- |
|
| Convertible
preferred stock |
|
|
- |
|
|
|
- |
|
|
|
451,710,162,027 |
|
|
|
- |
|
| Weighted
average number of shares of common stock outstanding during the period - diluted |
|
|
31,401,420,083 |
|
|
|
10,569,572,256 |
|
|
|
503,057,511,874 |
|
|
|
4,130,876,898 |
|
| Net
income (loss) per share of common stock available to common stockholders - basic: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Continuing
operations |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
0.00 |
|
|
$ |
(0.08 |
) |
| Discontinued
operations |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
| Total
basic |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
0.00 |
|
|
$ |
(0.08 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net
income (loss) per share of common stock available to common stockholders - diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Continuing
operations |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
0.00 |
|
|
$ |
(0.08 |
) |
| Discontinued
operations |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
| Total
diluted |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
0.00 |
|
|
$ |
(0.08 |
) |
|
| Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share |
Schedule of Anti-dilutive Securities Excluded from Computation of
Earnings Per Share
| |
|
2023 |
|
|
2022 |
|
| |
|
Three
Months September 30, |
|
| |
|
2023 |
|
|
2022 |
|
| Warrants |
|
|
511,333,351,089 |
|
|
|
511,333,351,092 |
|
| Convertible
preferred stock |
|
|
444,750,633,333 |
|
|
|
466,707,633,333 |
|
| Convertible
debentures |
|
|
28,777,833,333 |
|
|
|
28,777,833,333 |
|
| Stock
options |
|
|
26 |
|
|
|
26 |
|
| Anti-dilutive
shares |
|
|
984,861,817,781 |
|
|
|
1,006,818,817,784 |
|
For
the nine months ended September 30, 2023 and 2022, the following potential common stock equivalents were excluded from the calculation
of diluted loss per share as their effect was anti-dilutive:
| |
|
2023 |
|
|
2022 |
|
| |
|
Nine
Months September 30, |
|
| |
|
2023 |
|
|
2022 |
|
| Warrants |
|
|
490,355,572,583 |
|
|
|
511,333,351,092 |
|
| Convertible
preferred stock |
|
|
- |
|
|
|
466,707,633,333 |
|
| Convertible
debentures |
|
|
28,777,833,333 |
|
|
|
28,777,833,333 |
|
| Stock
options |
|
|
26 |
|
|
|
26 |
|
| Anti-dilutive
shares |
|
|
519,133,405,942 |
|
|
|
1,006,818,817,784 |
|
|